Literature DB >> 17084921

Increased aortic stiffness in glycogenosis type 2 (Pompe's disease).

Attila Nemes, Osama I I Soliman, Marcel L Geleijnse, Ashraf M Anwar, Nadine A M E van der Beek, Pieter A van Doorn, Henriette Gavallér, Eva Csajbók, Folkert J ten Cate.   

Abstract

BACKGROUND: Pompe's disease, also known as acid maltase deficiency or glycogen storage disease type II, is an autosomal recessive disorder in which deficient activity of the enzyme acid alpha-glucosidase causes intra-lysosomal accumulation of glycogen in muscle and other tissues. The current study was designed to assess aortic stiffness index (beta), as a characteristic of aortic elasticity during transthoracic echocardiography in patients with Pompe's disease.
METHODS: A total of 17 patients (age 44+/-8 years, 5 males) with Pompe's disease were studied. Their results were compared to 17 age- and gender-matched controls. In all patients, the ascending aorta was recorded with M-mode echocardiography. Beta was calculated as ln(SBP/DBP)/[(SD-DD)/DD], where SBP and DBP are the systolic and diastolic blood pressures, SD and DD are the systolic and diastolic aortic diameters, and 'ln' is the natural logarithm.
RESULTS: Diastolic aortic diameter was 27.4+/-2.4 mm in Pompe patients and 25.6+/-2.7 mm in controls (P<0.05). Systolic aortic diameters did not differ between the groups (29.4+/-2.5 mm vs 28.3+/-2.4 mm, P=ns). Aortic stiffness index (beta) was increased in Pompe patients compared to controls (14.6+/-10.1 vs 5.1+/-2.6, P<0.001).
CONCLUSIONS: The results of this study indicate that aortic stiffness is increased in patients with Pompe's disease. This may be due to glycogen storage in the vessel wall causing reduced vascular elasticity.

Entities:  

Mesh:

Year:  2006        PMID: 17084921     DOI: 10.1016/j.ijcard.2006.07.215

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

Review 1.  Multisystem late onset Pompe disease (LOPD): an update on clinical aspects.

Authors:  Antonio Toscano; Carmelo Rodolico; Olimpia Musumeci
Journal:  Ann Transl Med       Date:  2019-07

2.  Improved efficacy of a next-generation ERT in murine Pompe disease.

Authors:  Su Xu; Yi Lun; Michelle Frascella; Anadina Garcia; Rebecca Soska; Anju Nair; Abdul S Ponery; Adriane Schilling; Jessie Feng; Steven Tuske; Maria Cecilia Della Valle; José A Martina; Evelyn Ralston; Russell Gotschall; Kenneth J Valenzano; Rosa Puertollano; Hung V Do; Nina Raben; Richie Khanna
Journal:  JCI Insight       Date:  2019-03-07

3.  Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease.

Authors:  Sabrina Sacconi; Jonathan D Bocquet; Stéphane Chanalet; Véronique Tanant; Leonardo Salviati; Claude Desnuelle
Journal:  J Neurol       Date:  2010-06-18       Impact factor: 4.849

4.  The mild form of mucopolysaccharidosis type I (Scheie syndrome) is associated with increased ascending aortic stiffness.

Authors:  Attila Nemes; Remco G M Timmermans; J H Paul Wilson; Osama I I Soliman; Boudewijn J Krenning; Folkert J ten Cate; Marcel L Geleijnse
Journal:  Heart Vessels       Date:  2008-04-04       Impact factor: 2.037

5.  Altered energy state reversibly controls smooth muscle contractile function in human saphenous vein during acute hypoxia-reoxygenation: Role of glycogen, AMP-activated protein kinase, and insulin-independent glucose uptake.

Authors:  Rajkumar Pyla; Prahalathan Pichavaram; Arwa Fairaq; Mary Anne Park; Mark Kozak; Vinayak Kamath; Vijay S Patel; Lakshman Segar
Journal:  Biochem Pharmacol       Date:  2015-07-23       Impact factor: 5.858

6.  Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice.

Authors:  Richard L Sidman; Tatyana Taksir; Jonathan Fidler; Michael Zhao; James C Dodge; Marco A Passini; Nina Raben; Beth L Thurberg; Seng H Cheng; Lamya S Shihabuddin
Journal:  J Neuropathol Exp Neurol       Date:  2008-08       Impact factor: 3.685

7.  Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy.

Authors:  Deniz Güngör; Juna M de Vries; Wim C J Hop; Arnold J J Reuser; Pieter A van Doorn; Ans T van der Ploeg; Marloes L C Hagemans
Journal:  Orphanet J Rare Dis       Date:  2011-06-01       Impact factor: 4.123

8.  Increased aortic stiffness and blood pressure in non-classic Pompe disease.

Authors:  Stephan C A Wens; Esther Kuperus; Francesco U S Mattace-Raso; Michelle E Kruijshaar; Esther Brusse; Kees C A G M van Montfort; Marjan Scheltens- de Boer; Eric J G Sijbrands; Ans T van der Ploeg; Pieter A van Doorn
Journal:  J Inherit Metab Dis       Date:  2014-01-10       Impact factor: 4.982

9.  Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases.

Authors:  Maria Paola Belfiore; Francesca Iacobellis; Emma Acampora; Martina Caiazza; Marta Rubino; Emanuele Monda; Maria Rosaria Magaldi; Antonietta Tarallo; Marcella Sasso; Valeria De Pasquale; Roberto Grassi; Salvatore Cappabianca; Paolo Calabrò; Simona Fecarotta; Salvatore Esposito; Giovanni Esposito; Antonio Pisani; Luigi Michele Pavone; Giancarlo Parenti; Giuseppe Limongelli
Journal:  PLoS One       Date:  2020-05-19       Impact factor: 3.240

10.  Differences of aortic stiffness and aortic intima-media thickness according to the type of initial presentation in patients with ischemic stroke.

Authors:  Hyun Ju Yoon; Kye Hun Kim; Sang Hyun Lee; Yi Rang Yim; Kyung Jin Lee; Keun Ho Park; Doo Sun Sim; Nam Sik Yoon; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong; Jeong Gwan Cho; Jong Chun Park
Journal:  J Cardiovasc Ultrasound       Date:  2013-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.